Company · CIK 1821586
MoonLake Immunotherapeutics
| CIK | 1821586 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | E9 |
| Business address | Switzerland |
| Listed | MLTX (Nasdaq) |
| First annual or quarterly report | 2020-12-03 |
Offerings
5 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-298192 | 2026-08-10 | 2026-08-10 | 1 | |
| 333-274286 | 2023-08-31 | 2026-06-24 | 5 | |
| 333-271546 | 2023-05-01 | 2023-06-29 | 5 | |
| 333-262643 | 2022-02-11 | 2023-05-04 | 9 | |
| 333-249197 | 2020-10-01 | 2020-10-21 | 5 |
Filings
26| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-08-10 | S-3ASRShelf registered | 333-298192 | 0001213900-26-087295 |
| 2026-06-24 | 424B5Shelf takedown | 333-274286 | 0001213900-26-071586 |
| 2026-06-22 | 424B5Shelf takedown | 333-274286 | 0001213900-26-070709 |
| 2025-11-05 | 424B5Shelf takedown | 333-274286 | 0001213900-25-106722 |
| 2023-09-11 | EFFECTDeclared effective | 333-274286 | 9999999995-23-002626 |
| 2023-08-31 | S-3Shelf registered | 333-274286 | 0001628280-23-031149 |
| 2023-06-29 | 424B5Shelf takedown | 333-271546 | 0001628280-23-023894 |
| 2023-06-26 | 424B5Shelf takedown | 333-271546 | 0001628280-23-023451 |
| 2023-05-11 | 424B5Shelf takedown | 333-271546 | 0001628280-23-017578 |
| 2023-05-09 | EFFECTDeclared effective | 333-271546 | 9999999995-23-001355 |
| 2023-05-04 | EFFECTDeclared effective | 333-262643 | 9999999995-23-001279 |
| 2023-05-01 | S-3Shelf registered | 333-271546 | 0001628280-23-014573 |
| 2023-03-27 | EFFECTDeclared effective | 333-262643 | 9999999995-23-000674 |
| 2022-08-02 | EFFECTDeclared effective | 333-262643 | 9999999995-22-002223 |
| 2022-07-26 | S-1/AAmendment | 333-262643 | 0001213900-22-041495 |
| 2022-07-15 | S-1/AAmendment | 333-262643 | 0001213900-22-039695 |
| 2022-05-02 | S-1/AAmendment | 333-262643 | 0001213900-22-023173 |
| 2022-03-14 | S-1/AAmendment | 333-262643 | 0001213900-22-012161 |
| 2022-03-08 | S-1/AAmendment | 333-262643 | 0001213900-22-011107 |
| 2022-02-11 | S-1Registration filed | 333-262643 | 0001213900-22-006626 |
| 2020-10-21 | 424B4Final prospectus | 333-249197 | 0001213900-20-032599 |
| 2020-10-19 | EFFECTDeclared effective | 333-249197 | 9999999995-20-002907 |
| 2020-10-16 | S-1/AAmendment | 333-249197 | 0001213900-20-031676 |
| 2020-10-14 | S-1/AAmendment | 333-249197 | 0001213900-20-031188 |
| 2020-10-01 | S-1Registration filed | 333-249197 | 0001213900-20-029401 |
| 2020-08-28 | DRSDraft made public | 377-03471 | 0001213900-20-024302 |